EFFECTS OF PHARMACEUTICAL INTERVENTION IN PATIENTS WITH HIGH BLOOD PRESSURE AND NO PHARMACOLOGICAL TREATMENT AT COMMUNITY PHARMACIES IN THE PROVINCE OF CORDOBA
DOI:
https://doi.org/10.31052/1853.1180.v21.n3.17739Keywords:
Arterial Pressure, Blood Pressure, Hypertension, Health Education, Community Pharmacy ServicesAbstract
Objective: to determine the prevalence of high blood pressure (BP) in patients with no pharmacological treatment for hypertension and assess the effect of pharmaceutical intervention (PI) on patients with high BP. Method: observational descriptive prospective study carried out in two phases at community pharmacies in the province of Cordoba. Result of PI was classified in three categories and the effect was evaluated by the variation of BP values. Results: 36 community pharmacies and 687 patients participated. A 41.8% had high BP. PI was done on 281 patients and it was positive in 87.9%. Regarding the effect of PI, 75.4% of patients reduced their BP values in at least one category. Conclusions: PIs were positive in most cases, and in 3 out of 4 patients it was possible to reduce BP values at least in one category.
Downloads
References
1.Bendersky M, Guzmán L, Piskorz D, Mijailovsky N. Guías FAC III. Comité de Epidemiología y Prevención de FAC. Abordaje de la Hipertensión Arterial [Internet]. Federación Argentina de Cardiología. 4to. Congreso Virtual de Cardiología; 2005 [consultado 28 Feb 2015]. Disponible en: http://www.fac.org.ar/ccvc/llave/c140/c140.pdf
2.Ingaramo RA (coordinador). Guías de la Sociedad Argentina de Hipertensión para el diagnostico, estudio, tratamiento y seguimiento de la hipertensión arterial [Internet]. [consultado 28 Feb 2015]. Disponible en: http://www.saha.org.ar/pdf/GUIA_SAHA_VERSION_COMPLETA.pdf
3.Drouin D, Campbell NR, Kaczorowski J and for the Canadian Hypertension Education Program and the Implementation Task Force. Implementation of recommendations on hypertension: The Canadian Hypertension Education Program. Can J Cardiol. May 2006; 22(7): 595–8.
4.The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)2013 ESH/ESC. Guidelines for the management of arterial hypertension. Journal of Hypertension 2013;31:1281-1357.
5.Carvajal HA. Situación de la hipertensión arterial en Argentina. Hipertensión y Riesgo Vascular 2013;30:101-6.
6.De All J, Lanfranconi M, Bledel I, Doval H, Hughes A, Laroti A, et-al. Prevalencia de la hipertensión arterial en poblaciones rurales del norte argentino. Hipertens Riesgo Vasc. 2012;29:31-5.
7.De Sereday MS, Gonzalez C, Giorgini D, de Loredo L, Braguinsky J, Cobeñas C, et-al. Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina. Diabetes Metab. 2004;30:335-9.
8.Luquez H, ,De Loredo L, Madoery R, Luquez H (h), Senestrari D. Síndrome Metabólico: prevalencia en dos comunidades de Cordoba ,Argentina de acuerdo a definiciones ATP III y OMS. Rev Fed Arg Cardiol 2005;34:80-95.
9.Nigro D, Vergottini JC, Kuschnir E, Bendersky M, Campo I, De Roiter HG, et al. Epidemiología de la hipertensión arterial en la ciudad de Córdoba, Argentina. Rev Fed Arg Cardiol. 1999;28: 69-75.
10.Luquez H, Madoery RJ, de Loredo L, De Roitter H, Lombardelli S, Capra R, et al. Prevalencia de hipertensión arterial y factores de riesgo asociados. Estudio Dean Funes (Provincia de Córdoba Argentina). Rev Fed Arg Cardiol. 1999;28:93-104.
11.Faus MJ, Amariles P, Martínez-Martínez F. Atención Farmacéutica conceptos, proceso y casos prácticos. Madrid, España: Ergon; 2008.
12.Sabater D, de A, Bellver O, Divisón JA, Gorostodi M, Perseguer Z, Segura J, et al. Guía de actuación para el farmacéutico comunitario en pacientes con hipertensión arterial y riesgo cardiovascular: Documento de consenso. Farmacéuticos Comunitarios. 2011;3(2):69-83.
13.Sabater-Hernández D, Sendra-Lillo J, Faus MJ, Martínez-Martínez F, de la Sierra A. Usefulness of blood pressure measurement by community pharmacists in the management of hypertension. J Manag Care Pharm. 2012;18(6):453-6.
14. OPS/OMS. Servicios farmacéuticos basados en la atención primaria de salud. SERIE La Renovación de la Atención Primaria de Salud en las Américas N 6. Washington DC: OPS; 2013.
15.Martínez S. Efectos de la intervención farmacéutica en pacientes con presión arterial elevada sin tratamiento farmacológico para la hipertensión [tesis]: Universidad de Granada; 2008.
16.Sabater-Hernández D, Sánchez-Villegas P, Lacampa P, Artiles-Campelo A, Jorge-Rodríguez ME, Faus MJ. Evaluation of the hypertensive state in treated patients: selection of appropriate blood pressure measurements per visit to the community pharmacy. Blood Press Monit. 2011;16(3):103-10.
17.Bex SD, Boldt AS, Needham SB, Bolf SM, Walston CM, Ramsey DC, et al. Effectiveness of a hypertension care management program provided by clinical pharmacists for veterans. Pharmacotherapy 2011;31(1):31-8.
18.Earl GL, Henstenburg JA. Dietary approaches to hypertension: a call to pharmacists to promote lifestyle changes. J Am Pharm Assoc 2012;52(5):637-45.
19.Evans CD, Watson E, Eurich DT, Taylor JG, Yakiwchuk EM, Shevchuk YM, et al. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. Ann Pharmacother. 2011;45(5):615-28.
20.Laliberté MC, Perreault S, Damestoy N, Lalonde L. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health. 2012 15;12:192.
21.Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007; 41(11):1770-81.
22.Martínez Pérez SR, Armando PD, Molina Guerra AC, Martí Pallarés M, Martínez Martínez F. Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain. Pharm World Sci. 2009;31(3):406-12.
23.Álvarez I; Armando PD; Laurenti L; Martínez P; Tenllado MI; Uema SAN. Implantación de servicios profesionales farmacéuticos a pacientes con presión arterial elevada o con tratamiento farmacológico para la hipertensión en farmacias de Córdoba (Argentina). En: Foro Farmacéutico de las Américas. Trabajos finales de integración de Servicios Farmacéuticos. IV Curso Virtual de Servicios Farmacéuticos basados en Atención Primaria en Salud para gestores. FFA; octubre 2015. p. 12-17. Disponible en: http://forofarmaceuticodelasamericas.org/wp-content/uploads/2015/11/13-10-2015_Libro-TFI-Foro-Farmaceutico-de-las-Americas.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2017 Escuela de Salud Pública y Ambiente. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).
How to Cite
